Skip to main content
. Author manuscript; available in PMC: 2017 May 13.
Published in final edited form as: Circ Res. 2016 Mar 22;118(10):1525–1539. doi: 10.1161/CIRCRESAHA.116.308501

Figure 5. Hcy derived ROS trigger endothelial casp1 activation.

Figure 5

HUVECs were cultured in 6cm dishes as in Fig.1. A&B, Cells were transduced by adenoviral ec-SOD (1 MOI) for 48hr, treated with PEG-catalase (25mg/mL) for 30m with refreshed medium, and then with L-Hcy (500µM) and/or LPS (10 µg/mL) for additional 24hr before subjected for cell death and casp1 activity analysis. A, Pyroptosis/apoptosis (anti-oxidants rescue, FCM). B, Casp1 activity (anti-oxidants rescue, FCM). C, H2O2 on Casp1 activity (casp1 inhibition rescue, FCM). Cells were pretreated with casp1 inhibitor or inhibitor of cathepsin B (a lysosomal cysteine protease) for 30m, and then treated with H2O2 (500 µM) for additional 24 hours before subjected for casp1 activity analysis. Numbers above on each bar is the percentage normalized by the mean of control. Data are representative of 4 separated experiments and presented as Mean±SEM. #, P<0.05 vs vehicle in A, B; *, P<0.05 vs non-treatment control; †, P<0.05 vs H2O2 treatment alone in C. Arrows indicate the direction of significant changes. Values are Mean±SEM; n=4.

HHS Vulnerability Disclosure